In vivo proton magnetic resonance spectroscopy in patients with neuroacanthocytosis

Parkinsonism and Related Disorders

Volumn 4, Issue 1, 1998, Pages 11-15

  Molina, José Antonio ^a   García Segura, Juan Manuel ^b   Benito León, Julián ^a   Jiménez Jiménez, Félix Javier ^c,d   Martínez, Vicente ^e   Viaño, Juan ^e   Bermejo, Félix ^a  

^a HOSPITAL UNIVERSITARIO 12 DE OCTUBRE   (Spain)

^b UNIVERSIDAD COMPLUTENSE DE MADRID   (Spain)

^c HOSPITAL UNIVERSITARIO PRÍNCIPE DE ASTURIAS   (Spain)

^d Clínica del Rosario ^*  (Spain)

^e Magnetic Resonance Unit   (Spain)

Author keywords

1H Magnetic resonance Spectroscopy; Choline; Myoinositol; Neuroacanthocytosis

Indexed keywords

CHOLINE; CREATINE; INOSITOL; LAMOTRIGINE; LEVODOPA; LISURIDE; N ACETYLASPARTIC ACID; PHENOBARBITAL; TRIHEXYPHENIDYL;

ACANTHOCYTOSIS; ADULT; ARTICLE; CASE REPORT; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DIFFERENTIAL DIAGNOSIS; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; NEUROLOGIC DISEASE; PATHOGENESIS; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE;

EID: 0032103812     PISSN: 13538020     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1353-8020(98)00008-X     Document Type: Article

References (17)

1. [1] Hardie RJ, Pullon HWH, Harding AE, Owen JS, Pires JM, Daniels GL, Imai Y, Misra VP, King RHM, Jacobs JM, Tippett P, Duchen LW, Thomas PK, Marsden CD. Neuroacanthocytosis. A clinical, haemathological and pathological study of 19 cases. Brain, 1991;114:13-49.
2. [2] Rinne JO, Daniel SE, Scaravilli F, Pires M, Harding AE, Marsden CD. The neuropathological features of neuroacanthocytosis. Mov Disord, 1994;9:297-304.
3. [3] de Yébenes JG, Brin MF, Mena MA, De Felipe C, Del Río RM, Bazán E, Martínez A, Fahn S, Del Río J, Vázquez A, Varela de Seijas E. Neurochemical findings in neuroacanthocytosis. Mov Disord, 1988;3:300-312.
4. [4] Dubinsky RM, Hallet M, Levey R, Di Chiro G. Regional brain glucose metabolism in neuroacanthocytosis. Neurology, 1989;39: 1253-1255.
5. [5] Webb PG, Sallasuta N, Kohler S, Raidy T, Moats RA, Hurd RE. Automated single-voxel proton MRS: technical development and multisite verification. Magn Reson Med, 1994;31:365-373.
6. 1H-NMR spectra of human brain in vivo. NMR Biomed, 1991;4:90-98.
7. 1H-NMR spectroscopic studies of brain. Neurosci Biobehav Rev, 1989;13:23-31.
8. [8] Agranoff BW, Hajra AK. Lipids. In: Siegel GJ, Agranoff BW, Albers RW, Molinoff PB, editors. Basic neurochemistry. New York: Raven Press, 1994:97-116.
9. [9] Berridge MJ. Inositol trisphosphate and diacylglycerol: Two interacting second messengers. Ann Rev Biochem, 1987;56:159-193.
10. [10] Anderson RA, Marchesi VT. Regulation of the association of membrane skeletal protein 4.1 with glycophorin by polyphosphoinositide. Nature, 1985;318:295-298.
11. [11] Gascard P, Pawelczyk T, Lowenstein JM, Cohen CM. The role of inositolphospholipids in the association of band 4.1 with the human erytrocythe membrane. Eur J Biochem, 1993;211:671-681.
12. [12] Berridge MJ, Irvine RF. Inositol phosphate and cell signaling. Nature, 1989;341:197-205.
13. [13] Sakai T, Antoku Y, Iwashita X, Goto I, Nagamatsu K, Shii H. Chorea-Acanthocythosis: Abnormal composition of covalently bound fatty acids of erythrocyte membrane proteins. Ann Neurol, 1991;29:664-669.
14. [14] Enjalbert A, Sladeczek F, Guillon G, Bertrand P, Shu L, Epelbaum J, García-Sáinz JA, Jard S, Lombard C, Kordon C. et al. Angiotensin II and dopamine modulate both cAMP and inositol-phosphate production in anterior pituitary cells. J Biol Chem, 1986;261:4071-4075.
15. [15] Miller BL, Moats RA, Shonk T, Ernts Th, Woolley S, Ross BD. Alzheimer's disease: Description of increased cerebral Myo-Inositol with proton MR spectroscopy. Radiology, 1993;187:433-437.
16. [16] Parnetti L, Lowenthal DT, Presciutti O, Pelliccioli GP, Palumbo R, Gobbi G, Chiarini P, Palumbo B, Tarducci R, Senin U. 1-H-MRS, MRI-based hippocampal volumetry, and 99mTc-HMPAO-SPECT in normal aging, aged-associated memory impairment, and probable Alzheimer's disease. J Am Geriatr Soc, 1996;44:133-138.
17. [17] Shonk T, Ross BD. Role of increased myo-inositol in the dementia of Down syndrome. Magn Reson Med, 1995;33:858-861.